Loading...

Biofrontera Inc.

BFRIW•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$0.11
$0.02(16.91%)

Biofrontera Inc. (BFRIW) AI-Powered Stock Analysis

See how Biofrontera Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full Disclaimer

Biofrontera Inc. (BFRIW) Stock Overall Grade

Biofrontera Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

B

Good

Grade Breakdown by Metric

See how each financial and market factor contributes to Biofrontera Inc.'s overall stock rating.

Forecast

C+

Score

55/100

Financial Growth

C

Score

40/100

Fundamental Growth

C

Score

43/100

Key Ratios

C

Score

42/100

Sector Comparison

B+

Score

75/100

Industry Comparison

A

Score

80/100

S&P 500 Benchmark

A

Score

85/100

Analyst Consensus

C+

Score

50/100

Component Analysis Explained

Understand the key factors behind each Biofrontera Inc. stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions

;